Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$17,500.00
Sep 1, 2022
Individual or sole proprietorship
Canada Graduate Scholarships – Master’s Program
168496
The Canada Graduate Scholarships-Master’s (CGS M) Program helps develop research skills and assist in the training of highly qualified personnel by supporting students who demonstrate a high standard of achievement in undergraduate and early graduate studies.
$17,500.00
Sep 1, 2022
Individual or sole proprietorship
Canada Graduate Scholarships – Master’s Program
168498
The Canada Graduate Scholarships-Master’s (CGS M) Program helps develop research skills and assist in the training of highly qualified personnel by supporting students who demonstrate a high standard of achievement in undergraduate and early graduate studies.
$1,776,068.00
Sep 1, 2022
Individual or sole proprietorship
Training Grant: Clinical Trials Training Platforms
168388
.
• Support the development of skills that increase the likelihood of employability and career prospects of trainees, researchers, healthcare professionals and clinical research professionals across sectors, by integrating training on:
o approaches to advance rigorous and responsible research (e.g., product development from discovery to commercialization; best practices in clinical trial design, recruitment, conduct and reporting; sex- and gender-based analysis plus [SGBA+] (WSC:#moreInformation); research data management, research involving Indigenous Peoples, ethics, unconscious bias, life cycle/life stage approaches to clinical trials);
o grant/proposal writing, budgeting, and peer review;
o Professional development skills (including transferrable skills, such as communication, analytical thinking, problem solving, project management, leadership, etc.);
o best practices in knowledge translation and implementation science; and
o diverse career options and opportunities available across the different sectors (private/for profit, public and not-for-profit)
$2,911,416.00
Sep 1, 2022
Individual or sole proprietorship
Training Grant: Clinical Trials Training Platforms
168392
.
• Support the development of skills that increase the likelihood of employability and career prospects of trainees, researchers, healthcare professionals and clinical research professionals across sectors, by integrating training on:
o approaches to advance rigorous and responsible research (e.g., product development from discovery to commercialization; best practices in clinical trial design, recruitment, conduct and reporting; sex- and gender-based analysis plus [SGBA+] (WSC:#moreInformation); research data management, research involving Indigenous Peoples, ethics, unconscious bias, life cycle/life stage approaches to clinical trials);
o grant/proposal writing, budgeting, and peer review;
o Professional development skills (including transferrable skills, such as communication, analytical thinking, problem solving, project management, leadership, etc.);
o best practices in knowledge translation and implementation science; and
o diverse career options and opportunities available across the different sectors (private/for profit, public and not-for-profit)
$4,314,242.00
Sep 1, 2022
Individual or sole proprietorship
Training Grant: Clinical Trials Training Platforms
168391
.
• Support the development of skills that increase the likelihood of employability and career prospects of trainees, researchers, healthcare professionals and clinical research professionals across sectors, by integrating training on:
o approaches to advance rigorous and responsible research (e.g., product development from discovery to commercialization; best practices in clinical trial design, recruitment, conduct and reporting; sex- and gender-based analysis plus [SGBA+] (WSC:#moreInformation); research data management, research involving Indigenous Peoples, ethics, unconscious bias, life cycle/life stage approaches to clinical trials);
o grant/proposal writing, budgeting, and peer review;
o Professional development skills (including transferrable skills, such as communication, analytical thinking, problem solving, project management, leadership, etc.);
o best practices in knowledge translation and implementation science; and
o diverse career options and opportunities available across the different sectors (private/for profit, public and not-for-profit)
$762,882.00
Sep 1, 2022
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
168406
The purpose of these funds is to provide the institution responsible for administering the Operating Grant: Clinical Trials Projects, with funding for indirect costs associated with hosting the CT Network as the Funding Opportunity was not eligible for consideration in the Research Support Fund program.
$210,462.00
Sep 1, 2022
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects - Indirect Costs
168409
The purpose of these funds is to provide the institution responsible for administering the Operating Grant: Clinical Trials Projects, with funding for indirect costs associated with hosting the CT Network as the Funding Opportunity was not eligible for consideration in the Research Support Fund program.
$2,919,785.00
Sep 1, 2022
Individual or sole proprietorship
Operating Grant: Clinical Trials Projects
168440
The specific objectives of this funding opportunity are, in the context of the Biomanufacturing and Life Sciences Strategy, to:
• Support research teams across the country in conducting clinical trials that apply intersectional study design, primary data collection, and analyses so that the outcomes and health benefits of these trials can be applied to Canada’s diverse population;
• Support the participation of Canadian sites in international clinical trials;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.
$17,500.00
Sep 1, 2022
Individual or sole proprietorship
Canada Graduate Scholarships – Master’s Program
166575
The Canada Graduate Scholarships-Master’s (CGS M) Program helps develop research skills and assist in the training of highly qualified personnel by supporting students who demonstrate a high standard of achievement in undergraduate and early graduate studies.
$2,849,643.00
Sep 1, 2022
Individual or sole proprietorship
Operating Grant: Evaluation BC exemption re. possession of illegal drugs
168191
The specific objectives of this funding opportunity are to:
• Generate evidence on the impacts, including the public health impacts and economic health impacts of this exemption in British Columbia through engagement of various stakeholder groups including PWUD, the general population, police forces and the criminal justice system;
• Foster cross-disciplinary collaboration and bilateral interaction with decision makers and knowledge users to address pressing evidence needs further to the evaluation in order to directly inform drug policy;
• Consider the impact of the local context and other factors, such as biological and social determinants (e.g., sex, gender, age, housing status and income, etc.) and sub-populations (e.g., those with severe opioid use disorder, youth, Indigenous peoples, rural, inner-urban, etc.), on the implementation of the exemption;
• Identify considerations for further evaluation activities, including insights and generalizable knowledge regarding implementation processes, barriers, and facilitators; and
• Advance evidence-based practices through knowledge dissemination activities.